Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP859193.RAYS1hK2C3Mj3MCmhruK3NPcCGadU7_cfM2EBd_EAC5-8130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859193.RAYS1hK2C3Mj3MCmhruK3NPcCGadU7_cfM2EBd_EAC5-8130_provenance.
• NP908499.RAqTSKGvJxrCo9rbfAEoWvlRlgiXjvHwhZYdeC1V2xITc130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908499.RAqTSKGvJxrCo9rbfAEoWvlRlgiXjvHwhZYdeC1V2xITc130_provenance.
• NP787610.RACQWFxlE6wKjpaDVVvi4LfdiaAvYeV48WqTHn_nSmJCw130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787610.RACQWFxlE6wKjpaDVVvi4LfdiaAvYeV48WqTHn_nSmJCw130_provenance.
• NP505854.RA_2dKWJKvIjmrCexIkrxVJMghpXtg2TwdBotGkubJIxU130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505854.RA_2dKWJKvIjmrCexIkrxVJMghpXtg2TwdBotGkubJIxU130_provenance.
• NP849055.RAMwYgF2SGM0VfCI-eyZKkmpVxrAHuSK9xh-HfbV2nr4A130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849055.RAMwYgF2SGM0VfCI-eyZKkmpVxrAHuSK9xh-HfbV2nr4A130_provenance.
• NP890299.RAIitHKky-TpZMIIVnde_5SZwotn9h7PD93fv5VlzuooE130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890299.RAIitHKky-TpZMIIVnde_5SZwotn9h7PD93fv5VlzuooE130_provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP844923.RATnPENQ3ByeteMbrzKH3mSSucrqwDWx4IBJzTlO8RcmM130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844923.RATnPENQ3ByeteMbrzKH3mSSucrqwDWx4IBJzTlO8RcmM130_provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP930600.RAXtTjqTCGpnA4oMAJrAlCGnoheZW67-EFDilnWT4hvlA130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930600.RAXtTjqTCGpnA4oMAJrAlCGnoheZW67-EFDilnWT4hvlA130_provenance.
• NP844982.RA39HNql1Q3fGZOZd1wXBtJCrdM-336o-1embZvj0QpRQ130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844982.RA39HNql1Q3fGZOZd1wXBtJCrdM-336o-1embZvj0QpRQ130_provenance.
• NP873470.RA5tBZ8FFoXLduK_v29nCT7vqZ9ZxvG5a1VJ5dxLcX0bI130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873470.RA5tBZ8FFoXLduK_v29nCT7vqZ9ZxvG5a1VJ5dxLcX0bI130_provenance.
• NP961097.RAzQcHH8xbGOJWvrmls0D4dkrB1jjAjFCmb0gN54OG8gI130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961097.RAzQcHH8xbGOJWvrmls0D4dkrB1jjAjFCmb0gN54OG8gI130_provenance.
• NP961100.RA8l9JCaE4SFWd8fhEjNbupW4DErEdG-CxP95JGpSS23I130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961100.RA8l9JCaE4SFWd8fhEjNbupW4DErEdG-CxP95JGpSS23I130_provenance.
• NP961101.RA168lb0HUQUCaEcHJly0L6DfUowzPReYgHnC7D3PtTEI130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961101.RA168lb0HUQUCaEcHJly0L6DfUowzPReYgHnC7D3PtTEI130_provenance.
• NP961106.RA7oyvzFBDNre6_SmqbysXciOyDWTHYLuJMv4pNbqVFV0130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961106.RA7oyvzFBDNre6_SmqbysXciOyDWTHYLuJMv4pNbqVFV0130_provenance.
• NP961107.RA57nfjg3MjPCBfaWPqehK_39_CYJE82QGJnD6RCJrj7A130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961107.RA57nfjg3MjPCBfaWPqehK_39_CYJE82QGJnD6RCJrj7A130_provenance.
• NP609399.RAMXrMLucBbIfTww1oF8wahEYpFsrvQ7TgcBIDdJ255V8130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609399.RAMXrMLucBbIfTww1oF8wahEYpFsrvQ7TgcBIDdJ255V8130_provenance.
• NP609537.RAIV_V_bl1LdcXlGm3weuA7LpiZ91Q8b0F196n2-8dtT8130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609537.RAIV_V_bl1LdcXlGm3weuA7LpiZ91Q8b0F196n2-8dtT8130_provenance.
• NP961095.RAZt2d4tZhnY6Tiv0HuEH6ht4hgo_BL7eVW0LdeW3J_m8130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961095.RAZt2d4tZhnY6Tiv0HuEH6ht4hgo_BL7eVW0LdeW3J_m8130_provenance.
• NP961102.RAQVlyKuY27N7yVFBaky0aUXuunzMWr11gJ-20o-hXK1s130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961102.RAQVlyKuY27N7yVFBaky0aUXuunzMWr11gJ-20o-hXK1s130_provenance.
• NP961103.RAbtofthWOjWKKkGaA-EBW4at5hYlhsv8rpEIgiOBLQGw130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961103.RAbtofthWOjWKKkGaA-EBW4at5hYlhsv8rpEIgiOBLQGw130_provenance.
• NP961104.RAcBdbmdeB2EAv0VdDCgBO1cnv0ZAOey52l-VTBdE0mBc130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961104.RAcBdbmdeB2EAv0VdDCgBO1cnv0ZAOey52l-VTBdE0mBc130_provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP961098.RAMRLGAG5SwJsI5ie_5LCaYhtKXmN_4c_xBUel9U_5zoA130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961098.RAMRLGAG5SwJsI5ie_5LCaYhtKXmN_4c_xBUel9U_5zoA130_provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP873456.RAPBcjbPnentULJ3OqC-ZSA6oC_L3rBj-Lr0v9mWuC7d8130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873456.RAPBcjbPnentULJ3OqC-ZSA6oC_L3rBj-Lr0v9mWuC7d8130_provenance.
• NP961096.RAtXA944voF1O0yyQJIlgQneXUuXW5xI6TNIxPXdbJHMs130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961096.RAtXA944voF1O0yyQJIlgQneXUuXW5xI6TNIxPXdbJHMs130_provenance.
• NP961108.RAkhua7dbTazEvG7p9l78hxFR-rDATdg4MH_gaJ9reSkE130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961108.RAkhua7dbTazEvG7p9l78hxFR-rDATdg4MH_gaJ9reSkE130_provenance.
• NP387078.RAs1LVGjkPMMqJT2YnAQJuEIAmeCmC_k_mvhuwO4Z1i38130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387078.RAs1LVGjkPMMqJT2YnAQJuEIAmeCmC_k_mvhuwO4Z1i38130_provenance.
• NP387355.RAirbk49ubEgOLn0Upfc1rbwC5sMXlVOyUazFnMKIi1mw130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387355.RAirbk49ubEgOLn0Upfc1rbwC5sMXlVOyUazFnMKIi1mw130_provenance.
• NP787647.RAkBi6V7BCGBNWJUKCpdd-Pf4fvG37gEy4B0rqRyKc3pE130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787647.RAkBi6V7BCGBNWJUKCpdd-Pf4fvG37gEy4B0rqRyKc3pE130_provenance.
• NP930610.RAv9Xv_nG1ALJyY8XBfqeI4Cw2PVesK-7mrIHTpZicxLc130_assertion description "[While AHRR has never been implicated in gene fusions before, NCOA2 is the 3'-partner in fusions with MYST3 and ETV6 in leukemias and with PAX3 and HEY1 in sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930610.RAv9Xv_nG1ALJyY8XBfqeI4Cw2PVesK-7mrIHTpZicxLc130_provenance.